HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A group of atopic dermatitis without IgE elevation or barrier impairment shows a high Th1 frequency: possible immunological state of the intrinsic type.

AbstractBACKGROUND:
Atopic dermatitis (AD) can be classified into the major extrinsic type with high serum IgE levels and impaired barrier, and the minor intrinsic type with normal IgE levels and unimpaired barrier.
OBJECTIVE:
To characterize the intrinsic type of Japanese AD patients in the T helper cell polarization in relation to the barrier condition.
METHODS:
Enrolled in this study were 21 AD patients with IgE<200kU/L (IgE-low group; 82.5±59.6kU/L) having unimpaired barrier, and 48 AD patients with IgE>500kU/L (IgE-high group; 8.050±10.400kU/L). We investigated filaggrin gene (FLG) mutations evaluated in the eight loci common to Japanese patients, circulating Th1, Th2 and Th17 cells by intracellular cytokine staining and flow cytometry, and blood levels of CCL17/TARC, IL-18, and substance P by ELISA.
RESULTS:
The incidence of FLG mutations was significantly lower in the IgE-low group (10.5%) than the IgE-high group (44.4%) (normal individuals, 3.7%). The percentage of IFN-γ-producing Th1, but not Th2 or Th17, was significantly higher in the IgE-low than IgE-high group. Accordingly, Th2-attracting chemokine CCL17/TARC, was significantly lower in the IgE-low than the IgE-high group. There were no differences between them in serum IL-18 levels, or the plasma substance P levels or its correlation with pruritus.
CONCLUSION:
The IgE-low group differed from the IgE-high group in that it had much less FLG mutations, increased frequency of Th1 cells, and lower levels of CCL17. In the intrinsic type, non-protein antigens capable of penetrating the unimpaired barrier may induce a Th1 eczematous response.
AuthorsRieko Kabashima-Kubo, Motonobu Nakamura, Jun-ichi Sakabe, Kazunari Sugita, Ryosuke Hino, Tomoko Mori, Miwa Kobayashi, Toshinori Bito, Kenji Kabashima, Koetsu Ogasawara, Yukiko Nomura, Toshifumi Nomura, Masashi Akiyama, Hiroshi Shimizu, Yoshiki Tokura
JournalJournal of dermatological science (J Dermatol Sci) Vol. 67 Issue 1 Pg. 37-43 (Jul 2012) ISSN: 1873-569X [Electronic] Netherlands
PMID22591815 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Biomarkers
  • CCL17 protein, human
  • Chemokine CCL17
  • FLG protein, human
  • Filaggrin Proteins
  • Interleukin-18
  • Intermediate Filament Proteins
  • Substance P
  • Immunoglobulin E
  • Interferon-gamma
Topics
  • Adolescent
  • Adult
  • Biomarkers (blood)
  • Case-Control Studies
  • Chemokine CCL17 (blood)
  • Child
  • DNA Mutational Analysis
  • Dermatitis, Atopic (blood, classification, genetics, immunology, pathology)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Filaggrin Proteins
  • Flow Cytometry
  • Humans
  • Immunoglobulin E (blood)
  • Immunohistochemistry
  • Interferon-gamma (metabolism)
  • Interleukin-18 (blood)
  • Intermediate Filament Proteins (genetics)
  • Japan
  • Male
  • Middle Aged
  • Mutation
  • Sensory Thresholds
  • Skin (immunology, metabolism, pathology)
  • Substance P (blood)
  • Th1 Cells (immunology)
  • Th17 Cells (immunology)
  • Th2 Cells (immunology)
  • Up-Regulation
  • Water Loss, Insensible
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: